Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Leticia Salinas-Vázquez"'
Autor:
Sergio Sauri-Suárez, Sandra Quiñones-Aguilar, Arturo Contreras-Marín, Erik Omar Ramiro-Guerrero, David Zúñiga-García, Leticia Salinas-Vázquez, Leonardo Llamas-López, Carolina León-Jiménez, Adriana García-Martell, Iliana González-Hernández, Erwin Chiquete, Silvia García
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0230959 (2020)
BackgroundAdherence to disease-modifying therapies is determinant to attain maximal clinical benefit in multiple sclerosis (MS). RebiSmart® is an electronic auto-injector for subcutaneous delivery of interferon β-1a (INF-β1a) that monitors adheren
Externí odkaz:
https://doaj.org/article/e050786ee9624372b11d50b8c41371f0
Autor:
Leticia Salinas-Vázquez, Leonardo Llamas-López, Sergio Sauri-Suárez, David Gilberto Zúñiga-García, Silvia García, Erik Omar Ramiro-Guerrero, Adriana García-Martell, Arturo Contreras-Marín, Carolina León-Jiménez, Iliana Fabiola González-Hernández, Sandra Quiñones-Aguilar, Erwin Chiquete
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0230959 (2020)
PLoS ONE
PLoS ONE
BackgroundAdherence to disease-modifying therapies is determinant to attain maximal clinical benefit in multiple sclerosis (MS). RebiSmart® is an electronic auto-injector for subcutaneous delivery of interferon β-1a (INF-β1a) that monitors adheren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcc860a4949cabe3a5667dc1bc875836
https://doaj.org/article/e050786ee9624372b11d50b8c41371f0
https://doaj.org/article/e050786ee9624372b11d50b8c41371f0